NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1003892829 M.D.
Verify on CMS → Marlene Schwartz, M.D.
Pulmonary Disease Physician in Willimantic, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,323 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 196 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.5/100
▲ 1 pts above national avg 83.1 · Above neutral
Industry payments
$33.02
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Marlene Schwartz, M.D. reported a CMS MIPS final score of 84.5/100 - above the 83.1 national average - and filed 1,009 Medicare Part D claims in 2023.
- 84.5/100
- MIPS score · +1 vs avg
- 1K
- Part D claims, 2023
- 41%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Marlene Schwartz, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
85 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Marlene Schwartz, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Marlene Schwartz, M.D. writes more Part D claims than 48% of them and scores higher on MIPS quality than 52% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Marlene Schwartz, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Marlene Schwartz, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Marlene Schwartz, M.D.?
Near national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
1,009 31% vs specialty avg
MIPS final score
84.5/100 1.4 pts vs avg
Specialty distribution in Connecticut
How Pulmonary Disease Physician compares to other specialties among Connecticut providers
Medicare quality performance, MIPS
Marlene Schwartz, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 84.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 84.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Marlene Schwartz, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 112 MANSFIELD AVE, Willimantic, CT, 06226, with a listed phone of (860) 456-7279. NPI 1003892829 was issued on 12/22/2005.
Medicare Part D records for calendar year 2023 show 1,009 prescription claims written by this provider, covering 196 Medicare beneficiaries and totaling roughly $396K in drug spend, split 59% brand-name and 41% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.5/100 for the 2023 performance year (Quality 79.3, Cost 59.6), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,323 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003892829 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 12/22/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
84.4788
Final Score
Avg: 83.1
79.2865
Quality
59.5997
Cost
100
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Marlene Schwartz, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$33
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Marlene Schwartz, M.D. - brand share 59.0%
Pulmonary Disease Physician average
59% brand-name claims vs 41% generic, on 1,009 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,009
Total Claims
$396K
Total Drug Cost
196
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,522
- Total Day Supply
- 43,925
- Brand vs Generic
- 59% brand / 41% generic
- Brand Drug Cost
- $370K
- Generic Drug Cost
- $26K
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.94
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 19, 65-74: 97, 75-84: 65, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Marlene Schwartz, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
149 claims
- Trelegy Ellipta
Trelegy Ellipta
147 claims
- Montelukast Sodium
Montelukast Sodium
106 claims
- Anoro Ellipta
Anoro Ellipta
62 claims
- Fluticasone Propio… 54
Fluticasone Propionate
54 claims
- Breo Ellipta 47
Breo Ellipta
47 claims
- Fluticasone-Salmet… 32
Fluticasone-Salmeterol
32 claims
- Incruse Ellipta 32
Incruse Ellipta
32 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 149 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 147 |
| Montelukast Sodium | 106 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 62 |
| Fluticasone Propionate | 54 |
| Breo Ellipta Fluticasone/Vilanterol | 47 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 32 |
| Incruse Ellipta Umeclidinium Bromide | 32 |
| Spiriva Respimat Tiotropium Bromide | 31 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 30 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Marlene Schwartz, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,323
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Marlene Schwartz, M.D.'s 1,009 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Schwartz.
Dr. Mubdiul Ali
M.D.
New Haven, CT
Dr. Naser Adeeb Aljundi
MD
New London, CT
Dr. Augustine Andoh-Duku
M.D
Danbury, CT
Dr. Mohammed Anwar
MD
Vernon, CT
Dr. Mircea Badara
M.D.
New Britain, CT
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Connecticut
Frequently Asked Questions
What is Marlene Schwartz, M.D.'s specialty? ▼
Marlene Schwartz, M.D. specializes in Pulmonary Disease Physician and practices in Willimantic, Connecticut. Credentials: M.D..
How much does Marlene Schwartz, M.D. prescribe under Medicare Part D? ▼
In 2023, Marlene Schwartz, M.D. wrote 1,009 Medicare Part D claims totaling $396K in drug costs for 196 beneficiaries.
What is Marlene Schwartz, M.D.'s Medicare quality score? ▼
Marlene Schwartz, M.D. has a CMS MIPS Final Score of 84.5/100 (Quality: 79.3, Cost: 59.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Marlene Schwartz, M.D. located? ▼
Marlene Schwartz, M.D. is located at 112 MANSFIELD AVE, Willimantic, CT, 06226. Phone: (860) 456-7279.
What is Marlene Schwartz, M.D.'s NPI number? ▼
Marlene Schwartz, M.D.'s National Provider Identifier (NPI) is 1003892829, issued on 12/22/2005.
Does Marlene Schwartz, M.D. prescribe more brand-name or generic drugs? ▼
Marlene Schwartz, M.D.'s prescribing is 59% brand-name and 41% generic drugs by claim count, with $370K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,323 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Marlene Schwartz, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Marlene Schwartz, M.D.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Trelegy Ellipta, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Marlene Schwartz, M.D. accept Medicare? ▼
Marlene Schwartz, M.D. appears in CMS Medicare data with 1,009 Part D claims and 196 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Marlene Schwartz, M.D.'s credentials? ▼
Marlene Schwartz, M.D.'s NPI is 1003892829 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.